share_log

CVS Health | DEF 14A: Definitive information statements

CVS Health | DEF 14A: Definitive information statements

西維斯健康 | DEF 14A:股東委託書決議
美股SEC公告 ·  04/06 04:10

Moomoo AI 已提取核心訊息

CVS Health Corporation (CVS Health) is set to hold its Annual Meeting of Stockholders on May 16, 2024, at 8:00 a.m. Eastern Time. The meeting will be conducted virtually to allow shareholders to participate regardless of their location. The agenda includes the election of directors, ratification of the independent registered public accounting firm for 2024, advisory approval of executive compensation, and a proposal to amend the 2017 Incentive Compensation Plan to increase the number of shares authorized for issuance. Additionally, four stockholder proposals will be considered, including an independent worker rights assessment, a policy to prohibit re-nomination of directors failing to receive a majority vote, a vote on 'excessive' golden parachutes, and a policy requiring directors to disclose their time allocation among commitments...Show More
CVS Health Corporation (CVS Health) is set to hold its Annual Meeting of Stockholders on May 16, 2024, at 8:00 a.m. Eastern Time. The meeting will be conducted virtually to allow shareholders to participate regardless of their location. The agenda includes the election of directors, ratification of the independent registered public accounting firm for 2024, advisory approval of executive compensation, and a proposal to amend the 2017 Incentive Compensation Plan to increase the number of shares authorized for issuance. Additionally, four stockholder proposals will be considered, including an independent worker rights assessment, a policy to prohibit re-nomination of directors failing to receive a majority vote, a vote on 'excessive' golden parachutes, and a policy requiring directors to disclose their time allocation among commitments. The Board of Directors recommends voting for the election of directors, ratification of the accounting firm, executive compensation, and the amendment to the incentive plan, and against all stockholder proposals. The meeting will also include a business presentation and a Q&A session. Shareholders as of the record date, March 18, 2024, are entitled to vote and have been provided with various methods to submit their votes.
CVS Health Corporation(CVS Health)定於美國東部時間2024年5月16日上午8點舉行年度股東大會。會議將以虛擬方式進行,允許股東無論身在何處都能參加。該議程包括董事選舉、批准2024年獨立註冊會計師事務所、諮詢批准高管薪酬,以及修改2017年激勵性薪酬計劃以增加批准發行股票數量的提案。此外,還將考慮四項股東提案,包括一項獨立的工人權利評估、一項禁止重新提名未能獲得多數票的董事的政策、對 “過多” 金色降落傘的投票,以及一項要求董事披露其在承諾中的時間分配的政策。董事會建議對董事選舉、批准會計師事務所、高管薪酬和激勵計劃修正進行投票,並反對所有股東提案。會議還將包括業務演示和問答環節。截至記錄日期,即2024年3月18日,股東有權投票,並已獲得各種提交選票的方法。
CVS Health Corporation(CVS Health)定於美國東部時間2024年5月16日上午8點舉行年度股東大會。會議將以虛擬方式進行,允許股東無論身在何處都能參加。該議程包括董事選舉、批准2024年獨立註冊會計師事務所、諮詢批准高管薪酬,以及修改2017年激勵性薪酬計劃以增加批准發行股票數量的提案。此外,還將考慮四項股東提案,包括一項獨立的工人權利評估、一項禁止重新提名未能獲得多數票的董事的政策、對 “過多” 金色降落傘的投票,以及一項要求董事披露其在承諾中的時間分配的政策。董事會建議對董事選舉、批准會計師事務所、高管薪酬和激勵計劃修正進行投票,並反對所有股東提案。會議還將包括業務演示和問答環節。截至記錄日期,即2024年3月18日,股東有權投票,並已獲得各種提交選票的方法。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息